ObjectiveTo better understand why immunosuppressed individuals with systemic lupus erythematosus (SLE) fail to receive influenza and pneumococcal vaccines.MethodsThese cross-sectional data were derived from the 2009 cycle of the Lupus Outcomes Study (LOS), an annual longitudinal telephone survey of individuals with confirmed SLE. Respondents were included in the analysis if they had taken immunosuppressive medications in the past year. We assessed any prior receipt of pneumococcal vaccine and influenza vaccine in the past year, and then elicited reasons for not receiving vaccination. We used bivariate statistics and multivariate logistic regression to assess frequency and predictors of reported reasons for not obtaining influenza or pneumoc...
Objective. Both antibody and cell-mediated responses are involved in the defense against influenza. ...
Live vaccines are not safe for immuno-compromised patients and should not be given to patients with ...
International audienceBackground: Invasive pneumococcal disease and respiratory tract infections are...
Patients with systemic lupus erythematosus (SLE) show decreased immune responsiveness and are vulner...
Patients with systemic lupus erythematosus (SLE) show decreased immune responsiveness and are vulner...
Objective: to assess the safety and efficacy of influenza vaccination in patients with systemic lupu...
Objective. To assess the safety and efficacy of influenza vaccination in patients with systemic lupu...
Systemic Lupus Erythematosus (SLE) is a chronic inflammatory condition that affects millions of peop...
Abstract Background Infections are a major cause of morbidity and mortality in systemic lupus (SLE)....
IntroductionCancer and infections are leading causes of mortality in systemic lupus erythematosus (S...
The immunological perturbations associated with systemic lupus erythematosus (SLE) put many patients...
Objective. In SLE, a decreased antibody response on influenza vaccination has been reported. In this...
The immunological perturbations associated with systemic lupus erythematosus (SLE) puts many patient...
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus causing Coronavirus disease ...
Background: Infections are important denominators of morbidity and mortality in patients with system...
Objective. Both antibody and cell-mediated responses are involved in the defense against influenza. ...
Live vaccines are not safe for immuno-compromised patients and should not be given to patients with ...
International audienceBackground: Invasive pneumococcal disease and respiratory tract infections are...
Patients with systemic lupus erythematosus (SLE) show decreased immune responsiveness and are vulner...
Patients with systemic lupus erythematosus (SLE) show decreased immune responsiveness and are vulner...
Objective: to assess the safety and efficacy of influenza vaccination in patients with systemic lupu...
Objective. To assess the safety and efficacy of influenza vaccination in patients with systemic lupu...
Systemic Lupus Erythematosus (SLE) is a chronic inflammatory condition that affects millions of peop...
Abstract Background Infections are a major cause of morbidity and mortality in systemic lupus (SLE)....
IntroductionCancer and infections are leading causes of mortality in systemic lupus erythematosus (S...
The immunological perturbations associated with systemic lupus erythematosus (SLE) put many patients...
Objective. In SLE, a decreased antibody response on influenza vaccination has been reported. In this...
The immunological perturbations associated with systemic lupus erythematosus (SLE) puts many patient...
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus causing Coronavirus disease ...
Background: Infections are important denominators of morbidity and mortality in patients with system...
Objective. Both antibody and cell-mediated responses are involved in the defense against influenza. ...
Live vaccines are not safe for immuno-compromised patients and should not be given to patients with ...
International audienceBackground: Invasive pneumococcal disease and respiratory tract infections are...